In a phase 3 clinical trial involving 407 participants, an international team of researchers found that a weekly dose of 2.4 milligrams of semaglutide significantly beat placebo treatments for reducing weight and relieving symptoms of obesity-related osteoarthritis over a 68 week period, improving the ability to complete physical activities like walking
In the progression of kidney disease and fibrosis, caspase-3 plays a crucial role in inducing cell death in renal cells
If your sleep has changed, stress has increased or fatigue is making it harder to stay active, these should be discussed during your medical review
Reporting side effects : If you suspect you have experienced a side effect from a food supplement or herbal product, you can report it to the MHRA Yellow Card scheme at yellowcard
People with a personal or family history of medullary thyroid carcinoma (MTC) or people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not take Ozempic
They can modulate immune responses
